Current Neuro-Oncology

Volume 25 Number 6
31 March 2023

Home > Publications > Current Neuro-Oncology > Volume 25, Year 2023 > Number 6, 31 March

Huang-Hobbs E, Cheng YT, Ko Y, Luna-Figueroa E, Lozzi B, Taylor KR, McDonald M, He P, Chen HC, Yang Y, Maleki E, Lee ZF, Murali S, Williamson M, Choi D, Curry R, Bayley J, Woo J, Jalali A, Monje M, Noebels JL, Harmanci AS, Rao G, Deneen B.
Remote neuronal activity drives glioma infiltration via Sema4f.
bioRxiv [Preprint]. 2023 Mar 16:2023.03.15.532832. doi: 10.1101/2023.03.15.532832. PMID: 36993539. Laboratory investigation. ˍ

Lavrador JP, Reisz Z, Sibtain N, Rajwani K, Baig Mirza A, Vergani F, Gullan R, Bhangoo R, Ashkan K, Bleil C, Zebian B, Clark B, Laxton R, King A, Bodi I, Al-Saraj S.
H3 G34-mutant high-grade gliomas: integrated clinical, imaging and pathological characterisation of a single-centre case series.
Acta Neurochir (Wien). 2023 Mar 16. doi: 10.1007/s00701-023-05545-2. PMID: 36929449. Observational study˰ ˍ

Quach S, Schwartz C, Aumiller M, Foglar M, Schmutzer M, Katzendobler S, El Fahim M, Forbrig R, Bochmann K, Egensperger R, Sroka R, Stepp H, Rühm A, Thon N.
Interstitial photodynamic therapy for newly diagnosed glioblastoma.
J Neurooncol. 2023 Mar 16. doi: 10.1007/s11060-023-04284-9. PMID: 36928699. Observational study. ˍ

Sang H, Cho YK, Han K, Koh EH.
Impact of abdominal obesity on the risk of glioma development in patients with diabetes: A nationwide population-based cohort study in Korea.
PLoS One. 2023 Mar 16;18(3):e0283023. doi: 10.1371/journal.pone.0283023. PMID: 36928679. Observational study. ˍ


Yuan J, Xu L, Chien CY, Yang Y, Yue Y, Fadera S, Stark AH, Schwetye KE, Nazeri A, Desai R, Athiraman U, Chaudhuri AA, Chen H, Leuthardt EC.
First-in-human prospective trial of sonobiopsy in glioblastoma patients using neuronavigation-guided focused ultrasound.
medRxiv [Preprint]. 2023 Mar 18:2023.03.17.23287378. doi: 10.1101/2023.03.17.23287378. PMID: 36993173. Interventional study. ˍ


Heggebø LC, Borgen IMH, Rylander H, Kiserud C, Nordenmark TH, Hellebust TP, Evensen ME, Gustavsson M, Ramberg C, Sprauten M, Magelssen H, Blakstad H, Moorthy J, Andersson K, Raunert I, Henry T, Moe C, Granlund C, Goplen D, Brekke J, Johannessen TA, Solheim TS, Marienhagen K, Humberset Ø, Bergström P, Agrup M, Dahl L, Gubanski M, Gojon H, Brahme CJ, Rydén I, Jakola AS, Vik-Mo EO, Lie HC, Asphaug L, Hervani M, Kristensen I, Rueegg CS, Olsen IC, Ledal RJ, Degsell E, Werlenius K, Blomstrand M, Brandal P.
Investigating survival, quality of life and cognition in PROton versus photon therapy for IDH-mutated diffuse grade 2 and 3 GLIOmas (PRO-GLIO): a randomised controlled trial in Norway and Sweden.
BMJ Open. 2023 Mar 20;13(3):e070071. doi: 10.1136/bmjopen-2022-070071. PMID: 36940951. Interventional study. ˍ


Grogan PT, Helgager JJ, Deming DA, Howard SP, Jenkins RB, Robins HI.
Case report: Radiographic complete response of radiation-induced glioblastoma to front-line radiotherapy: A report and molecular characterization of two unique cases.
Front Neurol. 2023 Mar 21;14:1099424. doi: 10.3389/fneur.2023.1099424. PMID: 37025206. Case report. ˍ

Cepeda S, Luppino LT, Pérez-Núñez A, Solheim O, García-García S, Velasco-Casares M, Karlberg A, Eikenes L, Sarabia R, Arrese I, Zamora T, Gonzalez P, Jiménez-Roldán L, Kuttner S.
Predicting Regions of Local Recurrence in Glioblastomas Using Voxel-Based Radiomic Features of Multiparametric Postoperative MRI.
Cancers (Basel). 2023 Mar 22;15(6):1894. doi: 10.3390/cancers15061894. PMID: 36980783. Observational study. ˍ

Greenhall GHB, Rous BA, Robb ML, Brown C, Hardman G, Hilton RM, Neuberger JM, Dark JH, Johnson RJ, Forsythe JLR, Tomlinson LA, Callaghan CJ, Watson CJE.
Organ Transplants From Deceased Donors With Primary Brain Tumors and Risk of Cancer Transmission.
JAMA Surg. 2023 Mar 22:e228419. doi: 10.1001/jamasurg.2022.8419. PMID: 36947028. Observational study. ˍ

Li PJ, Lai SZ, Jin T, Ying HJ, Chen YM, Zhang P, Hang QQ, Deng H, Wang L, Feng JG, Chen XZ, Guo P, Chen M, Tian Y, Chen YY.
Radiotherapy opens the blood-brain barrier and synergizes with anlotinib in treating glioblastoma.
Radiother Oncol. 2023 Mar 22:109633. doi: 10.1016/j.radonc.2023.109633. PMID: 36963438. Laboratory investigation˰ ˍ

Oraee-Yazdani S, Akhlaghpasand M, Rostami F, Golmohammadi M, Tavanaei R, Shokri G, Hafizi M, Oraee-Yazdani M, Zali AR, Soleimani M.
Case report: Stem cell-based suicide gene therapy mediated by the herpes simplex virus thymidine kinase gene reduces tumor progression in multifocal glioblastoma.
Front Neurol. 2023 Mar 22;14:1060180. doi: 10.3389/fneur.2023.1060180. PMID: 37034076. Case report. ˍ

Hedrich C, Gojo J, Azizi A, Peyrl A, Slavc I, Winter F, Czech T, Dorfer C.
Placement of EVD in pediatric posterior fossa tumors: safe and efficient or old-fashioned? The Vienna experience.
Childs Nerv Syst. 2023 Mar 23. doi: 10.1007/s00381-023-05917-0. PMID: 36951979. Observational study. ˍ

Marak JR, Narayan S, Harsha G, Kaif M.
Primary glioblastoma of cerebellopontine angle: The diagnostic dilemma of this rare case.
Radiol Case Rep. 2023 Mar 23;18(5):2005-2010. doi: 10.1016/j.radcr.2023.02.042. PMID: 37006833. Case report. ˍ

Villani V, Casini B, Tanzilli A, Lecce M, Rasile F, Telera S, Pace A, Piludu F, Terrenato I, Rollo F, De Nicola F, Fanciulli M, Pallocca M, Ciliberto G, Carosi M. The Glioma-IRE project - Molecular profiling in patients with glioma: steps toward an individualized diagnostic and therapeutic approach.
J Transl Med. 2023 Mar 23;21(1):215. doi: 10.1186/s12967-023-04057-y. PMID: 36959606. Observational study. ˍ

Wang M, Yu J, Zhang J, Pan Z, Chen J.
Intraoperative ultrasound in recurrent gliomas surgery: Impact on residual tumor volume and patient outcomes.
Front Oncol. 2023 Mar 23;13:1161496. doi: 10.3389/fonc.2023.1161496. PMID: 37035181. Observational study. ˍ

Moss RM, Sorajja N, Mills LJ, Moertel CL, Hoang TT, Spector LG, Largaespada DA, Williams LA.
Sex differences in methylation profiles are apparent in medulloblastoma, particularly among SHH tumors.
Front Oncol. 2023 Mar 24;13:1113121. doi: 10.3389/fonc.2023.1113121. PMID: 37035203. Laboratory investigation. ˍ

Nagase T, Ishida J, Sasada S, Sasaki T, Otani Y, Yabuno S, Fujii K, Uneda A, Yasuhara T, Date I.
IDH-mutant Astrocytoma Arising in the Brainstem with Symptom Improvement by Foramen Magnum Decompression: A Case Report.
NMC Case Rep J. 2023 Mar 24;10:75-80. doi: 10.2176/jns-nmc.2022-0159. PMID: 37065877. Case report. ˍ

Santellan-Hernandez JO, Alvarez-Castro JA, Aguilar-Hidalgo KM, Soto FC, Escalante JR, Ichikawa-Escamilla E, Silva MJA, Mejia-Perez SI.
Multifocal glioblastoma and hormone replacement therapy in a transgender female.
Surg Neurol Int. 2023 Mar 24;14:106. doi: 10.25259/SNI_104_2023. PMID: 37025534. Case report. ˍ

Yuan Y, Qiu T, Chong ST, Hsu SP, Chu YH, Hsu YC, Xu G, Ko YT, Kuo KT, Yang Z, Zhu W, Lin CP, Song J.
Automatic bundle-specific white matter fiber tracking tool using diffusion tensor imaging data: A pilot trial in the application of language-related glioma resection.
Front Oncol. 2023 Mar 24;13:1089923. doi: 10.3389/fonc.2023.1089923. PMID: 37035157. Interventional study. ˍ

Lad BM, Beniwal AS, Jain S, Shukla P, Jung J, Shah SS, Yagnik G, Babikir H, Nguyen AT, Gill S, Young JS, Lui A, Salha D, Diaz A, Aghi MK.
Glioblastoma induces the recruitment and differentiation of hybrid neutrophils from skull bone marrow.
bioRxiv [Preprint]. 2023 Mar 25:2023.03.24.534105. doi: 10.1101/2023.03.24.534105. PMID: 36993266. Laboratory investigation. ˍ

Ringel A, Elhasid R, Constantini S, Roth J, Dvir R.
Significant response to targeted treatment with alectinib for intramedullary pediatric spinal high-grade glioma with ALK fusion.
Pediatr Blood Cancer. 2023 Mar 25:e30312. doi: 10.1002/pbc.30312. PMID: 36965191.
Authorea [Preprint]. February 13, 2023. doi: 10.22541/au.167627526.63609485/v1. Case report˰ ˍ

Troschel FM, Troschel BO, Kloss M, Troschel AS, Pepper NB, Wiewrodt RG, Stummer W, Wiewrodt D, Theodor Eich H.
Cervical body composition on radiotherapy planning computed tomography scans predicts overall survival in glioblastoma patients.
Clin Transl Radiat Oncol. 2023 Mar 27;40:100621. doi: 10.1016/j.ctro.2023.100621. PMID: 37008514. Observational study. ˍ

Leblond P, Tresch-Bruneel E, Probst A, Néant N, Solas C, Sterin A, Boulanger T, Aerts I, Faure-Conter C, Bertozzi AI, Chastagner P, Entz-Werlé N, De Carli E, Deley ML, Bouche G, André N.
Phase I Study of a Combination of Fluvastatin and Celecoxib in Children with Relapsing/Refractory Low-Grade or High-Grade Glioma (FLUVABREX).
Cancers (Basel). 2023 Mar 28;15(7):2020. doi: 10.3390/cancers15072020. PMID: 37046681. Interventional study. ˍ

Aymeric A, Louis-Marie T, Gabrielle C, Vincent J, Benoit M, Romuald S, Evelyne E, Luc B, Vincent R, Jimmy V, Christophe J, Emmanuel M, Leslie L, Bertrand M, Pierre-Jean LR, Andres C, Antoine P, Valérie R, Karima M, Audrey R, Philippe M, Dominique FB, Guillaume G, Kaissar F, Johan P, Ilyess Z.
Natural history of spinal cord metastasis from brain glioblastomas.
J Neurooncol. 2023 Mar 29. doi: 10.1007/s11060-023-04298-3. PMID: 36991306. Observational study˰ ˍ

El-Hemaly A, El-Ayadi M, Ahmed S, Taha H, Said M, Refaat A, Ammar H, Maher E, Badawy E, Reda M, El-Beltagy M, Zaghloul MS, El-Haddad A.
Prognostic factors affecting infantile medulloblastoma outcomes in the molecular era: a 12-year single-center experience from Egypt.
Future Oncol. 2023 Mar 29. doi: 10.2217/fon-2022-0559. PMID: 36987975. Observational study˰ ˍ

Quan G, Wang T, Ren JL, Xue X, Wang W, Wu Y, Li X, Yuan T.
Prognostic and predictive impact of abnormal signal volume evolution early after chemoradiotherapy in glioblastoma.
J Neurooncol. 2023 Mar 29. doi: 10.1007/s11060-023-04299-2. PMID: 36991305. Observational study˰ ˍ

Zha B, Yang J, Dang Q, Li P, Shi S, Wu J, Cui H, Huangfu L, Li Y, Yang D, Zheng Y.
A phase I clinical trial of sonodynamic therapy combined with temozolomide in the treatment of recurrent glioblastoma.
J Neurooncol. 2023 Mar 29. doi: 10.1007/s11060-023-04292-9. PMID: 36988745. Interventional study˰ ˍ

Khatchadourian C, Guo J, Prasad CJ, Orlando RA, Parsa C.
Report of multiple high-grade gliomas in two patients with shared retained ATRX, wild-type IDH, losses of CDKN2A genes and alterations in the PTEN-PI3K axis.
J Surg Case Rep. 2023 Mar 30;2023(3):rjad139. doi: 10.1093/jscr/rjad139. PMID: 37008737. Case report. ˍ

Lygina E, Morgacheva D, Khadela A, Postwala H, Shah Y, Dinikina Y.
Effectiveness of metronomic chemotherapy in a child with medulloblastoma: A case report.
Oncol Lett. 2023 Mar 30;25(5):194. doi: 10.3892/ol.2023.13780. PMID: 37113402. Case report. ˍ

Thompson EM, Landi D, Brown MC, Friedman HS, McLendon R, Herndon JE 2nd, Buckley E, Bolognesi DP, Lipp E, Schroeder K, Becher OJ, Friedman AH, McKay Z, Walter A, Threatt S, Jaggers D, Desjardins A, Gromeier M, Bigner DD, Ashley DM.
Recombinant polio-rhinovirus immunotherapy for recurrent paediatric high-grade glioma: a phase 1b trial.
Lancet Child Adolesc Health. 2023 Mar 30. doi: 10.1016/S2352-4642(23)00031-7. PMID: 37004712. Interventional study˰ ˍ

Zhou J, Shi LF, Wang Z, Li M, Zhang JS, Mao Y, Hua W.
OLIG2 expression level could be used as an independent prognostic factor for patients with cerebellar Glioblastoma (cGBM).
Clinics (Sao Paulo). 2023 Mar 30;78:100120. doi: 10.1016/j.clinsp.2022.100120. PMID: 37001387. Observational study. ˍ

Baqai MWS, Aziz HF, Qazi SS, Faisal KS, Shah SMI.
Glioblastoma imitating a cavernoma radiologically: A unique image report.
Surg Neurol Int. 2023 Mar 31;14:112
. doi: 10.25259/SNI_976_2022. PMID: 37151445. Case report. ˍ

Lai M, Li S, Li H, Hu Q, Li J, Zhou J, Ai R, Zhen J, Zhou Z, Wang L, Zhang Y, Hu W, Yuan L, Ma X, Zhang X, Song C, Li Z, Cai L.
Lorlatinib for ALK-fused, infant-type hemispheric glioma with lung metastasis: a case report.
Ann Clin Transl Neurol. 2023 Mar 31. doi: 10.1002/acn3.51766. PMID: 37000961. Case report. ˍ

Luo C, Yang J, Liu Z, Jing D.
Predicting the recurrence and overall survival of patients with glioma based on histopathological images using deep learning.
Front Neurol. 2023 Mar 31;14:1100933. doi: 10.3389/fneur.2023.1100933. PMID: 37064206. Observational study. ˍ

Sangtongjaraskul S, Sae-Phua V, Amornfa J, Tuchinda L.
Risk factors of intraoperative blood transfusion in pediatric craniotomy for intracranial tumor resection: a 10-year analysis.
J Neurosurg Pediatr. 2023 Mar 31:1-9. doi: 10.3171/2023.2.PEDS22535. PMID: 37021754. Observational study˰ ˍ

Werlenius K, Kinhult S, Solheim TS, Magelssen H, Löfgren D, Mudaisi M, Hylin S, Bartek J Jr, Strandéus M, Lindskog M, Rashid HB, Carstam L, Gulati S, Solheim O, Bartek J, Salvesen Ø, Jakola AS.
Effect of Disulfiram and Copper Plus Chemotherapy vs Chemotherapy Alone on Survival in Patients With Recurrent Glioblastoma: A Randomized Clinical Trial.
JAMA Netw Open. 2023 Mar 31;6(3):e234149. doi: 10.1001/jamanetworkopen.2023.4149. PMID: 37000452. Interventional study. ˍ

Zhang D, Fan T, Fan W, Zhao X, Liang C, Wang Y, Wu K.
Clinical Characteristics and Treatment Outcomes of Long-Level Intramedullary Spinal Cord Tumors: A Consecutive Series of 43 Cases.
Neurospine. 2023 Mar 31;20(1):231-239. doi: 10.14245/ns.2244648.324. PMID: 37016869. Observational study. ˍ